Brown Advisory’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-31,822
| Closed | -$4.55M | – | 1204 |
|
|
2021
Q4 | $4.55M | Sell |
31,822
-1,000
| -3% | -$172K | 0.01% | 490 |
|
|
2021
Q3 | $6.8M | Buy |
32,822
+60
| +0.2% | +$13.2K | 0.01% | 420 |
|
|
2021
Q2 | $6.96M | Sell |
32,762
-293
| -0.9% | -$53.7K | 0.01% | 421 |
|
|
2021
Q1 | $5.99M | Buy |
33,055
+29,585
| +853% | +$5.9M | 0.01% | 437 |
|
|
2020
Q4 | $387K | Hold |
3,470
| – | – | ﹤0.01% | 832 |
|
|
2020
Q3 | $376K | Sell |
3,470
-37,000
| -91% | -$4.51M | ﹤0.01% | 783 |
|
|
2020
Q2 | $3.37M | Sell |
40,470
-6,625
| -14% | -$253K | 0.01% | 434 |
|
|
2020
Q1 | $639K | Buy |
47,095
+13,295
| +39% | +$112K | ﹤0.01% | 638 |
|
|
2019
Q4 | $134K | Sell |
33,800
-2,000
| -6% | -$8.67K | ﹤0.01% | 1004 |
|
|
2019
Q3 | $179K | Buy |
35,800
+10,650
| +42% | +$58.3K | ﹤0.01% | 956 |
|
|
2019
Q2 | $147K | Buy |
25,150
+11,500
| +84% | +$90.5K | ﹤0.01% | 991 |
|
|
2019
Q1 | $150K | Buy |
13,650
+4,373
| +47% | +$138K | ﹤0.01% | 1268 |
|
|
2018
Q4 | $341K | Hold |
9,277
| – | – | ﹤0.01% | 1039 |
|
|
2018
Q3 | $349K | Hold |
9,277
| – | – | ﹤0.01% | 1109 |
|
|
2018
Q2 | $249K | Hold |
9,277
| – | – | ﹤0.01% | 1163 |
|
|
2018
Q1 | $390K | Sell |
9,277
-3,318
| -26% | -$133K | ﹤0.01% | 897 |
|
|
2017
Q4 | $312K | Buy |
12,595
+4,460
| +55% | +$109K | ﹤0.01% | 1032 |
|
|
2017
Q3 | $185K | Buy |
8,135
+3,480
| +75% | +$77.9K | ﹤0.01% | 1132 |
|
|
2017
Q2 | $108K | Sell |
4,655
-34
| -0.7% | -$667 | ﹤0.01% | 1186 |
|
|
2017
Q1 | $120K | Sell |
4,689
-250
| -5% | -$6.88K | ﹤0.01% | 1131 |
|
|
2016
Q4 | $124K | Sell |
4,939
-2,980
| -38% | -$86.9K | ﹤0.01% | 1095 |
|
|
2016
Q3 | $329K | Buy |
7,919
+3,230
| +69% | +$417K | ﹤0.01% | 853 |
|
|
2016
Q2 | $682K | Hold |
4,689
| – | – | ﹤0.01% | 667 |
|
|
2016
Q1 | $484K | Buy |
4,689
+350
| +8% | +$37.5K | ﹤0.01% | 727 |
|
|
2015
Q4 | $728K | Buy |
4,339
+20
| +0.5% | +$3.08K | ﹤0.01% | 615 |
|
|
2015
Q3 | $610K | Buy |
4,319
+75
| +2% | +$16.8K | ﹤0.01% | 648 |
|
|
2015
Q2 | $945K | Hold |
4,244
| – | – | ﹤0.01% | 536 |
|
|
2015
Q1 | $702K | Hold |
4,244
| – | – | ﹤0.01% | 621 |
|
|
2014
Q4 | $503K | Buy |
4,244
+694
| +20% | +$72.5K | ﹤0.01% | 684 |
|
|
2014
Q3 | $296K | Hold |
3,550
| – | – | ﹤0.01% | 801 |
|
|
2014
Q2 | $328K | Hold |
3,550
| – | – | ﹤0.01% | 778 |
|
|
2014
Q1 | $322K | Buy |
3,550
+150
| +4% | +$16.8K | ﹤0.01% | 769 |
|
|
2013
Q4 | $348K | Hold |
3,400
| – | – | ﹤0.01% | 721 |
|
|
2013
Q3 | $215K | Hold |
3,400
| – | – | ﹤0.01% | 781 |
|
|
2013
Q2 | $140K | Buy |
+3,400
| New | +$147K | ﹤0.01% | 775 |
|
Other funds holding NVAX
RCM
Brown Advisory's NVAX Position: Q1 2022 in Review
Brown Advisory sold out of Novavax (NVAX) in Q1 2022, closing a stake of 31,822 shares — an estimated $4.55M sold.
Brown Advisory first reported a position in NVAX in Q2 2013 and held it in 35 quarters. The position peaked at $6.96M in Q2 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.
- Brown Advisory reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
- Brown Advisory sold 31,822 Novavax shares in Q1 2022, an estimated $4.55M.
- Brown Advisory first reported a position in Novavax in Q2 2013 and held it in 35 quarters.
- Brown Advisory's Novavax position peaked at $6.96M in Q2 2021.
- 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.
Based on Brown Advisory's 13F filing for Q1 2022, filed 9 May 2022.